Accustem Sciences Inc.

ACUT

Accustem Sciences Inc.

ACUT

Insider Sentiment (TTM):

Last Purchase:2025-06-13Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:N/AInstitutional Shares Owned:N/AShares Outstanding:N/AInstitutional Ownership Pct.:N/A

Earnings Market Reaction:

Filing Date:2026-05-15Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash	0	0	0	0	0	0	0	0	0	0	0	0
Prepaid Expense Current	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets Current	-	-	2	2	2	-	-	-	-	-	-	-
Assets Current	0	0	2	2	2	0	0	0	0	0	0	0
Property Plant And Equipment Net	-	-	-	-	0	0	0	0	0	0	0	0
Other Assets	2	2	-	-	-	-	-	-	-	-	-	-
Assets	2	2	2	2	2	0	0	0	0	0	0	0
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	1	1	1	1	1	1	1	1	1	1	0	0
Other Liabilities Current	5	4	3	3	3	2	2	2	2	1	1	-
Accrued Liabilities Current	0	0	0	0	0	0	0	0	0	0	0	0
Notes Payable Current	-	0	0	0	-	0	0	0	-	0	0	0
Liabilities Current	5	5	4	4	4	3	3	3	3	2	2	2
Liabilities	5	5	4	4	4	3	3	3	3	2	2	2
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	6	6	6	6	6	5	4	4	4	4	4	4
Retained Earnings Accumulated Deficit	-10	-10	-9	-9	-8	-8	-8	-7	-7	-7	-6	-6
Stockholders Equity	-4	-3	-3	-3	-2	-3	-3	-3	-3	-2	-2	-1
Liabilities And Stockholders Equity	2	2	2	2	2	0	0	0	0	0	0	0
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	150	150	150	150	150	150	150	150	150	150	150	150
Common Stock Shares Issued	16	16	16	16	16	12	11	11	11	11	11	11
Shares Outstanding	16	16	16	16	16	12	11	11	11	11	11	11

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-1.88%	-40.21%	-19.68%	-	-	-	-	-	-	-	-	-
2025	113.85%	94.23%	280.62%	7.65%	-21.86%	-33.88%	-10.91%	-5.41%	-30.23%	-11.08%	-25.80%	-54.78%
2024	27.31%	8.23%	67.75%	-35.19%	-32.41%	-46.26%	-27.52%	19.05%	-13.15%	0.00%	-7.64%	63.82%
2023	-	-	-	1.78%	-4.08%	-13.98%	-4.98%	-5.03%	-29.68%	-24.40%	6.27%	-3.83%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	0.01	0.01	0.35	0.39	0.42	0.01	0.03	0.05	0.02	0.06	0.12	0.26
Quick Ratio	0.00	0.00	0.34	0.37	0.41	0.00	0.01	0.02	0.00	0.01	0.03	0.07
Working Capital	-5.37M	-4.90M	-2.91M	-2.53M	-2.16M	-3.31M	-3.19M	-2.89M	-2.62M	-2.12M	-1.89M	-1.31M
Leverage & Debt
Debt to Equity	-1.40	-1.46	-1.54	-1.64	-1.72	-1.02	-1.03	-1.05	-1.02	-1.06	-1.14	-1.35
Debt Ratio	3.50	3.20	2.85	2.57	2.39	66.16	31.76	21.65	52.43	16.77	8.32	3.85
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-0.11	-0.12	-0.10	-0.10	-0.11	-0.13	-0.12	-0.15	-0.15	-0.18	-0.25	-0.27
Free Cash Flow Per Share TTM	-0.06	-0.06	-0.05	-0.03	-0.06	-0.06	-0.08	-0.10	-0.12	-0.14	-0.17	-0.19
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	26.97%	16.68%	17.02%	-6.51%	-18.64%	-26.60%	-50.45%	-46.51%	-53.98%	-45.26%	-	-
EPS Growth (1Y)	0.52%	-12.41%	-17.38%	-34.00%	-27.44%	-27.17%	-50.45%	-46.51%	-53.98%	-46.86%	-	-
Valuation Metrics
P/E TTM	-3.39	-7.06	-16.83	-10.21	-4.66	-3.40	-3.14	-2.42	-2.28	-3.46	-3.60	-5.19
P/B TTM	-1.58	-3.64	-9.33	-6.21	-3.07	-1.55	-1.36	-1.38	-1.52	-3.36	-5.32	-12.24
Market Cap	6.11M	12.39M	27.16M	15.75M	6.62M	5.12M	4.34M	3.98M	3.97M	7.10M	10.02M	16.00M
Enterprise Value	6.10M	12.40M	27.19M	15.78M	6.58M	5.14M	4.36M	4.02M	3.96M	7.13M	10.07M	16.18M
Calculated Values
Free Cash Flow TTM	-934.38K	-850.39K	-872.33K	-486.15K	-716.90K	-664.07K	-959.51K	-1.09M	-1.41M	-1.62M	-1.94M	-2.15M
Net Debt	-12.21K	8.62K	30.30K	35.09K	-36.38K	20.10K	20.52K	35.15K	-9.37K	34.20K	41.74K	177.23K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-06-13Purchase

Owner: Cerrone, Gabriele M

Title: -

Shares: 2,400

Price/Share: $1.05

Value: $2,520.00

Shares Owned: 6,502,400

Relationship: Director,TenPercentOwner

Ownership: Indirect

2025-06-12Purchase

Owner: Cerrone, Gabriele M

Title: -

Shares: 8,991

Price/Share: $0.83

Value: $7,462.53

Shares Owned: 6,500,000

Relationship: Director,TenPercentOwner

Ownership: Indirect

2025-04-09Purchase

Owner: Cerrone, Gabriele M

Title: -

Shares: 3,000

Price/Share: $0.67

Value: $2,010.00

Shares Owned: 4,910,759

Relationship: Director,TenPercentOwner

Ownership: Indirect

2025-04-07Purchase

Owner: Cerrone, Gabriele M

Title: -

Shares: 52,802

Price/Share: $0.63

Value: $33,265.26

Shares Owned: 4,872,759

Relationship: Director,TenPercentOwner

Ownership: Indirect

2024-12-31Purchase

Owner: Cerrone, Gabriele M

Title: -

Shares: 100,000

Price/Share: $0.38

Value: $38,000.00

Shares Owned: 4,719,957

Relationship: Director,TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-06-13	Cerrone, Gabriele M	Director,TenPercentOwner	-	Indirect	Purchase	2,400	1.05	$2,520.00	6,502,400	4
2025-06-12	Cerrone, Gabriele M	Director,TenPercentOwner	-	Indirect	Purchase	8,991	0.83	$7,462.53	6,500,000	4
2025-04-09	Cerrone, Gabriele M	Director,TenPercentOwner	-	Indirect	Purchase	3,000	0.67	$2,010.00	4,910,759	4
2025-04-07	Cerrone, Gabriele M	Director,TenPercentOwner	-	Indirect	Purchase	52,802	0.63	$33,265.26	4,872,759	4
2024-12-31	Cerrone, Gabriele M	Director,TenPercentOwner	-	Indirect	Purchase	100,000	0.38	$38,000.00	4,719,957	4
2022-12-30	Cerrone, Gabriele M	Director,TenPercentOwner	-	Indirect	Purchase	5,000	1.40	$7,000.00	3,864,452	4
2022-12-02	Cerrone, Gabriele M	Director,TenPercentOwner	-	Indirect	Purchase	3,729	1.42	$5,295.18	3,859,452	4
2022-11-18	Cerrone, Gabriele M	Director,TenPercentOwner	-	Indirect	Purchase	24,500	1.05	$25,725.00	3,855,723	4
2022-08-01	Cerrone, Gabriele M	Director,TenPercentOwner	-	Indirect	Purchase	10,000	0.79	$7,900.00	3,831,223	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

No institutional ownership data available.

Accustem Sciences Inc. (ACUT) — SEC Financial Statements & Analysis

Accustem Sciences Inc. (ACUT) is a pharmaceutical preparations company, incorporated in DE. Accustem Sciences Inc. trades on OTC as: ACUT. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Accustem Sciences Inc. reported a Debt-to-Equity ratio of -1.40x, a Price-to-Book (P/B) ratio of -1.58 (TTM), at a market cap of $6.11M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: -1.40x
P/B TTM: -1.58
Market Cap: $6.11M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Accustem Sciences Inc. in?

Accustem Sciences Inc. (ACUT) operates in the Pharmaceutical Preparations industry.

What is ACUT's market cap?

Accustem Sciences Inc. (ACUT) has a market capitalization of $6.11M as of 2026-03-31.

What exchange does ACUT trade on?

Accustem Sciences Inc. (ACUT) trades on the OTC.

Where is Accustem Sciences Inc. incorporated?

Accustem Sciences Inc. is incorporated in DE.

Accustem Sciences Inc. (ACUT) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.